Taurine

Taurine is a sulfur-containing amino acid found in high concentrations in the heart, brain, skeletal muscle, and retina. Unlike most amino acids, it is not incorporated into proteins; instead it acts as a metabolic regulator, involved in bile acid conjugation, osmotic balance, calcium signaling, and antioxidant defense. The body synthesizes taurine from cysteine and methionine, but synthesis capacity is limited , making dietary intake particularly important. Meat, fish, shellfish, and dairy are the primary food sources. Vegans and vegetarians tend to have measurably lower plasma taurine levels.

Taurine Decline and Aging {#longevity-aging}

A landmark 2023 paper in Science (Singh et al., PMID 37289866) reported that cross-sectional blood samples showed apparent age-related taurine decline: levels in 60-year-old humans appeared roughly one-third of those in young adults. The study found that supplementation extended median lifespan by 10–12% in mice and improved healthspan markers in monkeys over six months , including reduced fasting blood glucose, improved bone density, and better immune cell profiles. These findings drew significant attention to taurine as a potential longevity intervention.

However, two independent 2025 publications have substantially weakened the foundational premise. A Science paper from NIH researchers (Fernandez et al., PMID 40472098) used longitudinal data from the Baltimore Longitudinal Study of Aging , tracking the same individuals over time , and found that circulating taurine concentrations increased or remained unchanged with age rather than declining. Within-individual variability in taurine far exceeded any age-related trend. The cross-sectional decline observed in the 2023 paper appears to reflect cohort differences rather than true aging-related depletion. A separate 2025 Aging Cell paper (PMC12507425) argued that even if some decline exists in certain populations, it is likely a downstream biomarker of aging-associated changes in diet and metabolism rather than a driver of aging itself.

The current evidence: the animal model data , lifespan extension in mice, healthspan improvement in monkeys , is real and well-documented. The cardiovascular and metabolic effects in humans are supported by RCT evidence (see below). But the core hypothesis that declining taurine is a causal aging mechanism in humans has been directly contradicted by longitudinal data. No large-scale longevity RCT in humans has been completed.

Cardiovascular Health {#cardiovascular-health}

Taurine is one of the most abundant free amino acids in cardiac muscle. It plays essential roles in regulating intracellular calcium flux, which underpins the force and rhythm of heart contractions. It also supports membrane stabilization and acts as an antioxidant within cardiomyocytes, helping to protect against oxidative stress. Lower plasma taurine is associated with increased cardiovascular disease risk in observational studies.

Meta-analyses of RCTs in humans show that taurine supplementation significantly reduces systolic and diastolic blood pressure compared to placebo, and improves functional markers in patients with heart failure. The blood pressure effect is modest but consistent, comparable in magnitude to dietary sodium reduction.

Metabolic Health {#metabolic-health}

Taurine is required for conjugation of bile acids in the liver, producing taurocholic acid and related bile salts that are essential for dietary fat digestion and absorption. This liver-dependent role means taurine status influences fat metabolism at a fundamental level. Additionally, taurine supplementation has been shown in human and animal studies to improve insulin sensitivity and attenuate post-meal blood glucose spikes. Some evidence suggests that acute endurance exercise transiently raises taurine levels, possibly reflecting mobilization from muscle stores. These metabolic effects likely operate through a combination of improved mitochondrial function, reduced oxidative stress in metabolically active tissues, and direct modulation of glucose uptake pathways.

Dosing and Safety

Studies have used doses ranging from 500 mg to 6 g/day. For general supplementation, 500 mg–1 g/day is the range most commonly referenced, consistent with the dose highlighted in longevity-focused protocols. The longevity animal studies used doses equivalent to roughly 500 mg–1 g/day in human-scaled estimates. Taurine is well tolerated across this range; no serious adverse effects have been reported in healthy adults in clinical research. It is not a stimulant. Taurine in energy drinks is present in low amounts and is not the source of any stimulant effect in those products.